Geode Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.9M Sell
427,546
-2,080
-0.5% -$136K ﹤0.01% 1782
2025
Q1
$28.8M Buy
429,626
+627
+0.1% +$42K ﹤0.01% 1696
2024
Q4
$23.7M Buy
428,999
+3,774
+0.9% +$209K ﹤0.01% 1886
2024
Q3
$25.4M Buy
425,225
+17,314
+4% +$1.03M ﹤0.01% 1849
2024
Q2
$26M Buy
407,911
+68,547
+20% +$4.37M ﹤0.01% 1786
2024
Q1
$23.5M Buy
339,364
+9,675
+3% +$669K ﹤0.01% 1822
2023
Q4
$18.2M Buy
329,689
+8,368
+3% +$461K ﹤0.01% 1972
2023
Q3
$18.7M Buy
321,321
+57,620
+22% +$3.35M ﹤0.01% 1868
2023
Q2
$14.2M Buy
263,701
+18,596
+8% +$1M ﹤0.01% 2079
2023
Q1
$9.74M Buy
245,105
+5,756
+2% +$229K ﹤0.01% 2270
2022
Q4
$9.63M Buy
239,349
+10,557
+5% +$425K ﹤0.01% 2288
2022
Q3
$7.35M Sell
228,792
-3,053
-1% -$98.1K ﹤0.01% 2451
2022
Q2
$6.88M Buy
231,845
+35,929
+18% +$1.07M ﹤0.01% 2510
2022
Q1
$5.51M Sell
195,916
-7,537
-4% -$212K ﹤0.01% 2740
2021
Q4
$9.38M Buy
203,453
+40,416
+25% +$1.86M ﹤0.01% 2482
2021
Q3
$5.35M Sell
163,037
-10,385
-6% -$341K ﹤0.01% 2874
2021
Q2
$6.08M Buy
173,422
+13,408
+8% +$470K ﹤0.01% 2781
2021
Q1
$5.78M Buy
160,014
+19,600
+14% +$708K ﹤0.01% 2717
2020
Q4
$4.08M Sell
140,414
-4,586
-3% -$133K ﹤0.01% 2707
2020
Q3
$4.09M Buy
145,000
+4,868
+3% +$137K ﹤0.01% 2518
2020
Q2
$4.53M Buy
140,132
+3,856
+3% +$125K ﹤0.01% 2391
2020
Q1
$5.55M Buy
136,276
+11,354
+9% +$462K ﹤0.01% 2085
2019
Q4
$7.7M Buy
124,922
+8,125
+7% +$501K ﹤0.01% 2187
2019
Q3
$8.51M Buy
116,797
+784
+0.7% +$57.1K ﹤0.01% 2044
2019
Q2
$9.54M Buy
116,013
+10,052
+9% +$826K ﹤0.01% 1995
2019
Q1
$7.47M Buy
105,961
+8,502
+9% +$600K ﹤0.01% 2090
2018
Q4
$4.39M Buy
97,459
+2,827
+3% +$127K ﹤0.01% 2298
2018
Q3
$5.35M Buy
94,632
+7,298
+8% +$413K ﹤0.01% 2317
2018
Q2
$5.83M Buy
87,334
+4,024
+5% +$269K ﹤0.01% 2235
2018
Q1
$4.85M Buy
83,310
+6,332
+8% +$369K ﹤0.01% 2251
2017
Q4
$4.96M Buy
76,978
+10,430
+16% +$672K ﹤0.01% 2222
2017
Q3
$3.49M Buy
66,548
+1,201
+2% +$63K ﹤0.01% 2415
2017
Q2
$3.06M Buy
65,347
+969
+2% +$45.3K ﹤0.01% 2473
2017
Q1
$3.19M Buy
64,378
+2,816
+5% +$139K ﹤0.01% 2388
2016
Q4
$3.73M Buy
61,562
+5,950
+11% +$361K ﹤0.01% 2254
2016
Q3
$3.69M Buy
55,612
+767
+1% +$50.9K ﹤0.01% 2155
2016
Q2
$3.06M Buy
54,845
+1,624
+3% +$90.6K ﹤0.01% 2206
2016
Q1
$1.79K Buy
53,221
+543
+1% +$18 ﹤0.01% 2537
2015
Q4
$2.38M Buy
52,678
+30
+0.1% +$1.35K ﹤0.01% 2350
2015
Q3
$2.08M Buy
52,648
+1,645
+3% +$65K ﹤0.01% 2421
2015
Q2
$3.16M Buy
51,003
+1,923
+4% +$119K ﹤0.01% 2213
2015
Q1
$3.07M Buy
49,080
+2,402
+5% +$150K ﹤0.01% 2165
2014
Q4
$2.63M Buy
46,678
+10,216
+28% +$576K ﹤0.01% 2252
2014
Q3
$1.03M Buy
36,462
+1,163
+3% +$32.9K ﹤0.01% 2759
2014
Q2
$1.22M Buy
35,299
+4,876
+16% +$168K ﹤0.01% 2676
2014
Q1
$953K Buy
30,423
+443
+1% +$13.9K ﹤0.01% 2821
2013
Q4
$601K Buy
29,980
+1,196
+4% +$24K ﹤0.01% 2995
2013
Q3
$281K Buy
28,784
+15,158
+111% +$148K ﹤0.01% 3173
2013
Q2
$82K Buy
+13,626
New +$82K ﹤0.01% 3453